FR2877668B1 - Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations - Google Patents

Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations

Info

Publication number
FR2877668B1
FR2877668B1 FR0452591A FR0452591A FR2877668B1 FR 2877668 B1 FR2877668 B1 FR 2877668B1 FR 0452591 A FR0452591 A FR 0452591A FR 0452591 A FR0452591 A FR 0452591A FR 2877668 B1 FR2877668 B1 FR 2877668B1
Authority
FR
France
Prior art keywords
final product
product obtained
intermediate compound
immunogenic molecules
coupling non
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0452591A
Other languages
English (en)
Other versions
FR2877668A1 (fr
Inventor
Michel Geffard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polyneuros SAS
Original Assignee
GEMAC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEMAC SA filed Critical GEMAC SA
Priority to FR0452591A priority Critical patent/FR2877668B1/fr
Priority to PCT/FR2005/050942 priority patent/WO2006051241A2/fr
Publication of FR2877668A1 publication Critical patent/FR2877668A1/fr
Application granted granted Critical
Publication of FR2877668B1 publication Critical patent/FR2877668B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR0452591A 2004-11-10 2004-11-10 Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations Expired - Fee Related FR2877668B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0452591A FR2877668B1 (fr) 2004-11-10 2004-11-10 Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations
PCT/FR2005/050942 WO2006051241A2 (fr) 2004-11-10 2005-11-10 Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0452591A FR2877668B1 (fr) 2004-11-10 2004-11-10 Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations

Publications (2)

Publication Number Publication Date
FR2877668A1 FR2877668A1 (fr) 2006-05-12
FR2877668B1 true FR2877668B1 (fr) 2007-07-06

Family

ID=34954138

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0452591A Expired - Fee Related FR2877668B1 (fr) 2004-11-10 2004-11-10 Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations

Country Status (2)

Country Link
FR (1) FR2877668B1 (fr)
WO (1) WO2006051241A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102008732B (zh) * 2010-11-08 2012-10-24 武汉华耀生物医药有限公司 一种叶酸偶联抗体药物及其制备方法与应用
US20190343951A1 (en) * 2017-01-13 2019-11-14 National Research Council Of Canada Method of optimizing peptide immuno-epitope by glycosylation, optimized peptide thereof and its use for conjugate vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876727A (en) * 1995-03-31 1999-03-02 Immulogic Pharmaceutical Corporation Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
US6455047B1 (en) * 1997-09-19 2002-09-24 Serex, Inc. Methods to improve immunogenicity of antigens and specificity of antibodies

Also Published As

Publication number Publication date
FR2877668A1 (fr) 2006-05-12
WO2006051241A3 (fr) 2006-11-09
WO2006051241A2 (fr) 2006-05-18

Similar Documents

Publication Publication Date Title
ATE447564T1 (de) Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol
IL184524A0 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
DE602006018429D1 (de) Verfahren zur herstellung von verschlüssen
ITUD20050070A1 (it) Processo per la produzione di catalizzatori
BRPI1005940A2 (pt) processo para preparar compostos de 2-nitrobifenila de fórmula i, compostos de 2-aminobifenila de fórmula vi, n-acil-2-aminobifenilas da fórmula geral (vii), composto de fórmula i, composto de fórmula ii, composto de fórmula iii e composto de fórmula x.1 ou x.2
FI20050023A0 (fi) Puun käsittelyaine, menetelmä puun käsittelemiseksi ja puutuote
BRPI0922381A2 (pt) "processo para síntese de di-ou oligossacarídeos de l-fucose e novos derivados intermediários de 2,3,4-tribenzil-fucose dos mesmos."
WO2008009831A3 (fr) Derives de cyclodextrines amphiphiles
IL191762A0 (en) Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
BRPI0817062A2 (pt) Composições emolientes e de poliamida, produtos produzidos e métodos de produção e utilização de tais composições e produtos.
ATE548368T1 (de) Harnstoffderivate, verfahren zu ihrer herstellung und ihre anwendungen
BRPI0718386A2 (pt) Processo para preparação de catalisadores.
BRPI0919918A2 (pt) Composto de vanilina e de etilvanilina, processo de preparação do mesmo, composição, e, aplicação do composto.
SE0500605L (sv) Metallprodukt, produktionsmetod och användning därav
FR2888844B1 (fr) Procede de synthese.
ITMO20050336A1 (it) Metodo per la produzione di componenti curvi da arredo, particolarmente ante per mobili
ZA200805382B (en) Keratin-binding effector molecules, and method for the production thereof
DE602006019903D1 (de) Verfahren zur herstellung von titanprodukten
DE502006002029D1 (de) Verfahren zur herstellung von polyetheraminen
ZA200706067B (en) Production process for NSAID-containing lozenges, their compositions, their medicinal use
BRPI0913445A2 (pt) processo para o tratamento da corrente aquosa proveniente da reação de fischer-tropsch
BRPI0906915A2 (pt) Processo para o tratamento da corrente aquosa proveniente da reação de fischer-tropsch
FR2936129B1 (fr) Produit comprenant des diamides, procede de preparation et utilisations
FR2877668B1 (fr) Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations
FI20050649A0 (fi) Menetelmä puun tai puutuotteiden käsittelemiseksi

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

CA Change of address

Effective date: 20200311

CD Change of name or company name

Owner name: POLYNEUROS, FR

Effective date: 20200311

ST Notification of lapse

Effective date: 20200906